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Background: Clinical trials are mandatory for evidence-based practice. Hardly, any data are available
regarding the number of clinical trials and their methodological quality that are conducted in allied ﬁelds
of medicine.
Objective: The present study was envisaged to assess methodological quality of trials in allied medical
ﬁelds.
Materials and Methods: Registered clinical trials in World Health Organization International Clinical
Trials Registry Platform (http://apps.who.int/trialsearch/AdvSearch.aspx) in the following ﬁelds were
extracted: Acupuncture; Ayurveda; biofeedback; complementary and alternate medicine; herbal; ho-
meopathy; massage; naturopathy; Reiki; Siddha; Unani; and yoga. The eligible studies were assessed for
the following key details: Type of sponsors; health condition in which the trial has been conducted;
recruitment status; study design; if randomization was present, method of randomization and allocation
concealment; single or multi-centric; retrospective or prospective registration; and publication status in
case of completed studies.
Results: A total of 276 clinical trials were registered majority of which have been proposed to be con-
ducted in the ﬁeld of oncology and psychiatry. Most of the clinical trials were done in single centers
(87.75%), and almost all the clinical trials were investigator-initiated with pharmaceutical company
sponsored studies contributing to a maximum extent of 24.5%. A large majority of the study designs were
interventional where almost 85% of the studies were randomized controlled trials. However, an
appropriate method of randomization was mentioned only in 27.4%, and the rate of allocation
concealment was found to be just 5.5%. Only 1e2% of the completed studies were published, and the
average rate of retrospective registration was found to be 23.6% in various ﬁelds.
Conclusion: The number of clinical trials done in allied ﬁelds of medicine other than the allopathic
system has lowered down, and furthermore focus is required regarding the methodological quality of
these trials and more support from various organizations.
© 2016 Transdisciplinary University, Bangalore and World Ayurveda Foundation. Publishing Services by
Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Clinical trials generate high-quality evidence that may then get
incorporated into national/international guidelines and meta-
analysis, ﬁnally culminating in an evidence-based practice (EBP)iences, College of Medicine,
ersity, Suva, Fiji.
).
ary University, Bangalore.
alore and World Ayurveda Foundat
es/by-nc-nd/4.0/).[1]. For EBP, clinical trials have to be conducted with robust
methodology and published to allow more transparency of the
ﬁndings. In this era of shared decision-making, even patients
should have access for such clinical trials, and this is the very
purpose of creating clinical trials registry platform. There exist
several regional clinical trial registries serving different regions of
the world and the World Health Organization International Clinical
Trial Registry Platform (WHO-ICTRP) initiated in 2006 serves as a
portal of access to these registries [2].ion. Publishing Services by Elsevier B.V. This is an open access article under the CC
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allopathic medicine revealed crucial ﬁndings [3,4] which include
poor quality of publication of clinical trials in complementary and
alternate systems of medicine [5] and dentistry [6] and also paucity
of available data regarding the clinical trial methodology in these
ﬁelds. In addition, there is no data on clinical trials conducted or
published in other allied ﬁelds of medicine such as acupuncture,
Ayurveda, homeopathy, massage, naturopathy, Reiki, Siddha, Unani,
and yoga. Hence, the present studywas envisagedwith an objective
to obtain a holistic view of methodological quality and trends of
clinical trials done in all these ﬁelds.2. Materials and methods
The study was conducted between September 2014 and January
2015. Following keywords were used for the search in WHO-ICTRP
(http://apps.who.int/trialsearch/AdvSearch.aspx): Acupuncture;
Ayurveda; biofeedback; complementary and alternate medicine
(CAM); herbal; homeopathy; massage; naturopathy; Reiki; Siddha;
Unani; and yoga. Individually, the above-mentioned keywords
were used in the “Intervention” sectionwithout any limits in either
the recruiting status or date of registration ﬁelds. Both authors
independently retrieved the studies from the trial registry
emerging from search results, and duplicate studies were removed
from the ﬁnal analysis.
Each of the registered studies was assessed for the following
details: Source of primary registry (Clinical Trial Registry of India
[CTRI], Chinese Clinical Trial Registry [ChiCTR], Korean Clinical Trial
Registry [KCT], clinicaltrials.gov [CTG], German Clinical Trials Reg-
ister [GermanCTR]; International Standards of Reporting Clinical
Trials [ISRCTN], Netherland's Trial Register [NTR], European Clinical
Trial Database [EudraCT], Brazilian Clinical Trial Registry [REBEC],
Iranian Registry of Clinical Trials [IRCT], Hong Kong Clinical Trial
Register, Australia and New Zealand Trial Register, Japan Clinical
Trial Registry [UMIN-CTR]); type of sponsors (academic or com-
mercial); health condition in which the trial has been conducted;
year of registration; Institutional Ethics Committee (IEC) approval
obtained or not; recruitment status (ongoing/completed); study
design (observational/interventional [nonrandomized/randomized
(open label, single blind, and double blind)]); if randomization was
done, method of randomization (computer generated [CG], random
number table [RNT]) and allocation concealment; phase of clinical
trials (I, II, III, and IV); single or multicentric; type of study partic-
ipants (patients/healthy volunteers); retrospective or prospective
registration; and publication status in case of completed studies.3. Results
3.1. Number of clinical trials
The search strategy revealed a total of 342 studies (acupuncture
e 3; Ayurveda e 11; biofeedback e 27; CAM e 9; herbal e 53;
homeopathy e 31; massage e 51; naturopathy e 15; Reiki e 9;
Siddha e 7; Unani e 7; and yoga e 119). Of the studies retrieved
under CAM (n ¼ 9), one was proposed to evaluate Ayurveda, two
studies retrieved under massage and one with naturopathy were
proposed to evaluate acupuncture and after removing the dupli-
cates and inappropriate studies, a total of 276 studies were included
in the ﬁnal analysis (acupuncture e 6; Ayurveda e 10; biofeedback
e 25; CAM e 8; herbal e 53; homeopathy e 21; massage e 38;
Reiki e 1; Siddha e 5; Unani e 2; and yoga e 107). A summary of
various characteristics and methodological quality of various clin-
ical trials is depicted in Table 1.3.2. Characteristics of clinical trials
3.2.1. Acupuncture
A total of six studies were retrieved (3 e ChiCTR; CTG e 2 [one
each in the United States (US) and United Kingdom (UK)] and one
fromKCT). All these studies were investigator-initiated (one each in
the years 2005, 2008, 2010, and 2011 and two in 2012) and only
four studies had mentioned that they had obtained IEC approval.
Regarding the health condition in which the clinical trials are car-
ried out in Acupuncture, one each was in ophthalmology (juvenile
myopia), psychiatry (attention deﬁcit hyperactivity disorder
[ADHD]), cardiovascular system (chronic stable angina) and
oncology (breast and head and neck cancer) and two were in the
ﬁeld of central nervous system disorders (cerebral palsy and spastic
paralysis). All the studies were being done in a single center in
patients, and only one study had been completed.
3.2.2. Ayurveda
There were a total of 10 studies (seven in CTG [US e 5; one each
in Singapore and France], two in CTRI and one in GermanCTR)
pertaining to this ﬁeld. All these studies were from academia (three
each in 2006 and 2007, two in 2012 and one each in 2009 and
2011). Regarding the health conditions where the studies are being
carried out, seven were in the ﬁeld of oncology (three in breast
cancer, two in all types of cancer patients and one each in prostate
cancer and chronic myeloid leukemia [CML]) and one each in
mental retardation and lifestyle. Furthermore, 9 of the 10 studies
are conducted in patients and one in healthy volunteers, seven are
being carried out in a single center and three are multi-centric and
only one was completed.
3.2.3. Biofeedback
A total of 24 studies were retrieved (15 e CTG [14 e US, 1 e
Taiwan], 3 e GermanCTR, two each from ISRCTN [both from UK]
and NTR, and 1 from ChiCTR) of which only 2/24 (8.3%) was from
commercial sponsors. A total of ﬁve studies were conducted each in
the ﬁeld of psychiatry (one each in ADHD and alcohol de addiction,
anxiety, cognitive behavioral therapy and psychotherapy) and uri-
nary incontinence, three each in the disorders of central nervous
system (two in cerebral palsy and one in migraine) and anal in-
continence, two with lower limb disorders (one each with quad-
riceps inhibition and drop foot) and one each in insomnia, pelvic
ﬂoor disorder, erectile dysfunction, cancer, diabetes mellitus, and
neuropathic pain. Only 9/24 (37.5%) studies had mentioned about
having obtained IEC approval, and a majority (23/24, 95.8%) were
done in a single center. In addition, only one study was completed,
and 23/24 (95.8%) studies were carried out in patients while only
one in a healthy volunteer.
3.2.4. Complementary and alternate medicine
A total of eight clinical trials (6 e CTG [5 e US and 1 eMexico],
one each from CTRI and ISRCTN [Chile]) were registered. All the
eight studies were from academia, and only three had mentioned
about IEC approval. Half of the studies were being carried out in
oncology (one each in CML, breast cancer, prostate cancer, and
ovarian cancer), two in human immunodeﬁciency virus-infected
patients and one each in ulcerative colitis and elderly population.
Five out of eight studies were completed; two are ongoing, and one
was terminated. All the studies were being carried out in a single
center in patients.
3.2.5. Herbal
Fifty-three clinical trials (19 each from CTG and CTRI; 9 e
ChiCTR; 3 e IRCT; 2 e UMINeCTR and one from ISCRTN) have been
registered of which 40 (75.5%) were from academics and 13 (24.5%)
Table 1
Summary of the analyses pertaining to registered clinical trials in allied medical ﬁelds from WHO-ICTRP (n [%]).
Types of
studies (n)
Observational Type of studies Methodological quality Retrospective
registration
Sponsored
studies
Multi-centric Completed Interventional Observational Mention of method of
randomization sequence
Mention of method of
allocation concealment
Acupuncture (6) 0 0 1 (16.7) 6 (100) 3 (50) 0 1 (16.7)
Ayurveda (10) 0 3 (30) 1 (10) 7 (70) 0 0 2 (20)
Biofeedback (24) 2 (8.3) 1 (4.2) 1 (4.2) 24 (100) 1 (4.8) 0 9 (37.5)
CAM (8) 0 0 5 (62.5) 1 (12.5) 0 0 5 (62.5)
Herbal (53) 13 (24.5) 13 (24.5) 3 (5.7) 49 (92.5) 4 (7.5) 10 (27.8) 4 (11.1) 23 (43.4)
Homeopathy (21) 0 2 (9.5) 0 20 (95.2) 6 (33.3) 1 (5.6) 3 (16.7)
Massage (38) 0 1 (2.6) 5 (13.2) 36 (94.7) 2 (5.3) 1 (2.8) 0 8 (21.1)
Yoga (107) 0 8 (7.5) 8 (7.5) 107 (100) 15 (18.3) 4 (4.9) 41 (38.3)
Others (5) 0 0 0 5 (100) 0 0 5 (100)
WHO-ICTRP: World Health Organization International Clinical Trial Registry Platform, CAM: Complementary and alternate medicine.
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studies had reported of having obtained IEC approval, and only 3
(5.7%) had been completed and none of these has been published.
In addition, 47 (88.7%) have reported patients as the study partic-
ipants and the rest in healthy individuals, and only 13/53 (24.5%)
were multi-centric and the remaining (40/53, 75.5%) were done in
single centers. Majority, 13 (24.5%) were being done in the ﬁeld of
dermatology and others are as follows: 6 (11.3%) each in oncology
and orthopedics; 5 (9.4%) e endocrinology; 4 (7.5%) e central
nervous system disorders; 3 (5.7%) each in infections, psychiatry
and respiratory tract; 2 (3.8%) each in patients with xerostomia and
metabolic disorders and 1 (1.9%) each in ENT and burns. Three
studies were completed, and none of them were published.
3.2.6. Homeopathy
A total of 21 studies (9 e CTG; 8 e CTRI; one each from EudraCT,
ISCRTN, NTR and REBEC) have been registered in this ﬁeld of which
10 (47.6%) had reported of having obtained IEC approval. Slightly
less than a third of studies (6/21, 28.6%) were reported in the ﬁeld of
oncology, 4 (19.1%) each in respiratory and psychiatry, 2 (9.6%) each
in orthopedics and diabetic foot and 1 (4.8%) each in dry eye syn-
drome, hormonal disorder and anesthesiology. All the studies were
reported to be currently ongoing, done in patients, and only 2/21
(9.5%) were multi-centric. Six studies were completed, and none of
them published.
3.2.7. Massage
Thirty-eight clinical studies (27 e CTG; 4 e IRTN; 3 e ISCRTN; 2
e REBEC and one each from ChiCTR and CTRI) have been registered
in this ﬁeld of which only one had mentioned of having obtained
IEC approval and all were investigator-initiated. A total of 11/38
(28.9%) were done in the ﬁeld of orthopedics; 6 (15.8%) each in
oncology and central nervous system disorders, 5 (13.2%) in psy-
chiatry, 3 (7.9%) in pediatric, 2 (5.3%) each in pregnant and fecal
incontinence, 1 (2.6%) each in dentistry, burns and lymphedema
patients. Only 1/38 (2.6%) was a multi-centric study, and 35/38
(92.1%) were done in patients and the remaining (3/38, 7.9%) in
healthy individuals. Five out of 38 were completed, and only 2/5
(40%) were published.
3.2.8. Yoga
A total of 107 clinical studies (72 were from CTG, 20 e CTRI, 4 e
NTR, 3 e UMINeCTR, 2 each in ISCTRN and IRTN and one each in
REBEC, ChiCTR, GermanCTR, and KCT) were registered in this ﬁeld
of which 25 reports of having obtained IEC approval. Slightly less
than a third of these studies (32/107, 29.9%) were being conducted
in the ﬁeld of psychiatry, 17/107 (15.9%) in oncology, 10/107 (9.3%)
in cardiovascular system, 11/107 (10.3%) in central nervous system
disorders, 8/107 (7.5%) each in orthopedics and metabolicdisorders, 5/107 in (4.7%) respiratory diseases, 3/107 (2.8%) in irri-
table bowel syndrome and one each in hormonal, genitourinary
and ophthalmology. Only 8/107 (7.5%) were multicentric, and none
of these had been published despite completion.
3.2.9. Others (Siddha, Unani, and Reiki)
A total of ﬁve clinical studies (two related to nephrology and one
each in the ﬁeld of orthopedics, metabolic and cardiovascular dis-
orders) were retrieved pertaining to Siddha and two in the ﬁeld of
Unani (one each in orthopedics and dermatology). All these were
registered in CTRI, investigator-initiated and had obtained IEC
approval and done in single centers. Only one clinical trial was
identiﬁed in Reiki registered in CTG that was ongoing in a single
center for patients with pain and fatigue.
3.3. Methodological quality of clinical trials
3.3.1. Acupuncture
All the six studies in this ﬁeld are interventional (two in Phase I
and one in Phase II and others did not mention) of which ﬁve were
randomized controlled clinical trials (RCT). Out of these, only three
mentioned the method used for randomization (2 e CG and 1 e
RNT) and all these studies did not mention anything about alloca-
tion concealment. Only one study has been completed and pub-
lished, and one other was retrospectively registered.
3.3.2. Ayurveda
A total of 7 out of 10 studies in Ayurveda were interventional
(RCT e 6 and nonRCT e 1; and one each were Phase II and III and
rest did not mention the phase of clinical trial) and the remaining
observational. None of these RCT mentioned the method of
randomization as well as allocation concealment. Only one study
was completed and published, and two were retrospectively
registered.
3.3.3. Biofeedback
All the 24 studies were interventional (21 [87.5%] e RCT and 3
[12.5%] e nonRCT and none mentioned the phase of clinical trial).
Of the 21 RCTs, only 1 (4.8%) mentioned the method of randomi-
zation (RNT), none about allocation concealment and only 5 (23.8%)
were blinded trials (three are single, and two are double). Only one
was completed and published, and 9/24 (37.5%) were retrospec-
tively registered.
3.3.4. Complementary and alternate medicine
Out of the eight studies, only one was interventional (RCT with
no mention on the method of randomization, allocation conceal-
ment, and open label). Five out of the total eight studies were
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studies were retrospectively registered.3.3.5. Herbal
Forty-nine (92.5%) clinical studies were interventional and 4
(7.5%) were observational. Of the 49 interventional studies, 36
(73.5%) were RCTs and 13 (26.5%) were nonRCTs. Only 10/36 (27.8%)
RCTs had mentioned a procedure for randomization (9 e CG and
one reported coin toss/shufﬂing cards/dice throw). Also, only 4/36
(11.1%) RCTs had reported a procedure for allocation concealment
(one each as SNOSE, precoded containers, pharmacy controlled,
and an open list of randomnumbers). Similarly, the phase of clinical
trials has beenmentioned in 30/49 registered studies (11e Phase 4;
7 e Phase 3; 6 e Phase 2; 3 e Phase 1 and one each had mentioned
Phase 1/2, 2/3 and 3/4). A total of 26/49 (53.1%) reported the use of
blinding technique (22 e double; 3 e single and 1 e triple) and the
remaining (23/49, 46.9%) were open-label studies.3.3.6. Homeopathy
A total of 20/21 (95.2%) studies were interventional (four each
were Phase 2 and 3; twowere Phase 1/2 and one had mentioned as
Phase 2/3) of which 18/20 (90%) were RCTs. Only 6/18 (33.3%) had
reported the procedure for randomization in which three had
mentioned the use of CG while the remaining three had wrongly
mentioned. Similarly, only 1/18 (5.6%) did mention the method of
allocation concealment and 15/18 (83.3%) studies use one of the
blinding techniques (14 e double; 1 e single) and the remaining
were open label. Also, 3/18 (16.7%) studies did register their studies
retrospectively.3.3.7. Massage
Out of the total 38, 36 (94.7%) studies were interventional (2 e
Phase 2; 1 each of Phase 4 and Phase 1/2 and 34 did not mention
any phase of drug development) and 2 (5.3%) were observational.
Thirty-three (91.7%) of 36 interventional studies were RCTs of
which only 1 (2.8%) had mentioned RNT as a method of randomi-
zation and none about the allocation concealment. A total of 14/38
(36.8%) used blinding technique (seven, each was single and
double-blinded) and 8/38 (21.1%) retrospectively registered their
studies.3.3.8. Yoga
All the studies (n ¼ 107) were interventional (9 e Phase 2; 5 e
Phase 1; 4 e Phase 1/2, 3 e Phase 2/3 and the rest did not mention
the phase of study) of which 82/107 (76.6%) were RCTs. Of these 82
RCTs, only 15 (18.3%) mentioned a procedure for randomization (9
e CG; 4 e coin toss and 2 e RNT) and only 4 (4.9%) a method for
concealing the allocation (two each SNOSE and central randomi-
zation). Nearly, half of the RCTs (42/82, 51.2%) were blinded (36 e
single and 6 were double blinded). A total of 41/107 (38.3%) were
retrospectively registered.3.3.9. Others (Siddha, Unani, and Reiki)
Of the ﬁve clinical studies in Siddha, 4 (80%) were done in pa-
tients, all the studies were nonrandomized, registered retrospec-
tively and only two had mentioned the development phase as
Phase 2. Both clinical studies in Unani were randomized (1 e CTG
and another had wrongly mentioned the method) and single
blinded. Also, only one out of the total two studies did mention
SNOSE as a method of allocation concealment. The single study in
Reiki was a nonrandomized open-label study without having
mentioned any phase of drug development and was prospectively
registered.4. Discussion
The present study was undertaken to understand the global
trend of clinical trials that were being conducted in the allied
medical ﬁelds that were registered in WHO-ICTRP. A total of 473
clinical studies have been registered majority being investigator-
initiated, in single centers and only a small fraction of the
completed studies were published. A large majority of the trials
were conducted in patients suffering from cancer, psychiatric dis-
eases, and central nervous system disorders except in the ﬁeld of
dentistry. Also, only a few studies have reported correct procedure
for randomization and allocation concealment in case of RCTs,
majority of the studies were open label and retrospectively
registered.
EBP plays a pivotal role in the creation of healthcare policy and
delivery of healthcare services [7]. For EBP to be effective, clinical
trials/studies are mandatory in all the medical ﬁelds. We found that
the total number of clinical trials done in ﬁelds other than the
modern system of medicine is very less. We hypothesize the
following factors to contribute for the same: Lack of trained re-
searchers, poor support both from the government organizations
and private pharmaceutical companies and absence of awareness of
patients towards various concepts and importance of clinical trials.
Furthermore, there can be more researches done in these areas due
to the unawareness these trials might not be registered in any of the
registries. Furthermore, the number of institutions dedicated to
such allied medical ﬁelds is relatively less than the modern allo-
pathic system of medicine. More programs in training the re-
searchers involved in these allied medical ﬁelds and funding from
various organizations both to support these researches and in
promoting the development of new institutions in these ﬁelds are
the need of the hour to improve the evidence generation. Also,
more incentives should be given to the private pharmaceutical
companies as there is a limited market in many foreign countries
for these allied ﬁelds of medicine.
Not only the number of clinical studies but also their quality
matter when it comes to acceptance of study results. Among
various types of studies, RCTs stand at the top next tometa-analysis
whose results are more credible, associated with lesser bias than
observational and nonrandomized interventional studies [8]. In the
present study, we found only few studies were RCTs irrespective of
the ﬁeld. To the best of our knowledge, this is the ﬁrst studywhere a
comprehensive assessment is done both for the number and quality
of studies conducted in the allied medical ﬁelds. Furthermore, even
those studies that have been designed as RCTs have not reported
the method of randomization and allocation concealment in an
appropriate way. The procedure of randomization involves gener-
ating the random sequence and not revealing the generated
sequence until an eligible study participant reaches the study site
which is the most important aspect. Randomization without con-
cealing allocation will not serve the purpose of reducing con-
founding and selection bias [9]. Surprisingly, only 1.5% of the
evaluated studies had reported the method of allocation conceal-
ment. The scenario has been similar in other ﬁelds of medicine as
evident from a systematic review of 3159 trials conducted in Chi-
nese traditional medicine, where only 4% had reported adequate
randomization method [10]. Considering the importance of the
same, Consolidated Standards of Reporting Trials, a widely known
guideline for reporting randomized trials has laid down themethod
of randomization and allocation concealment as one of the essen-
tial 25 reporting items [11]. Also, another widely used scale for
assessing the quality of RCTs, Jadad scale, considers both these
essential elements [12]. Unlike allocation concealment, use of
blinding technique to reduce the ascertainment bias is not essential
for all RCTs. When present, blinding increases the credibility of the
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course, may compromise the external validity in some cases [13].
Reports have documented an exaggeration of the treatment effect
to an extent of 17% in case of open-label design than those using the
blinding strategy [14]. Only a small fraction of the evaluated studies
in the present study used one of the blinding techniques while a
large majority was of open-label design. More focus is required in
improving themethodological quality of studies conducted in these
ﬁelds.
We also found that only a few of the completed clinical trials are
published eventually. Only the published data forms a source for
EBP. Studies that had assessed the publication fraction of registered
clinical trials in the registry reported a publishing rate of only
46e70% [15,16]. It is unethical not to publish the results of a
completed study irrespective of the nature of ﬁndings, and this
constitutes a scientiﬁc misconduct. There exists a need for
increasing the awareness for making the data available both for the
scientiﬁc community and public.
The study is limited in the fact that we restricted to elicit the
characteristics of the trials from the WHO-ICTRP without actually
trying to contact any of the investigators and there can be modi-
ﬁcations in any/many of the trials before/during the conduct of
clinical trials.5. Conclusion
The number of clinical trials done in allied ﬁelds of medicine
other than allopathic system are low down, and furthermore focus
is required regarding the methodological quality of these trials and
more support from various organizations.Source of support
Nil.Conﬂicts of interest
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